• Explore /
  • Poster
  • / Safety and tolerability of oxaliplatin based pressurized intraperitoneal aerosol chemotherapy (PIPAC) for patients with peritoneal carcinomatosis: A phase I dose-finding study in Asian patients.

Safety and tolerability of oxaliplatin based pressurized intraperitoneal aerosol chemotherapy (PIPAC) for patients with peritoneal carcinomatosis: A phase I dose-finding study in Asian patients.

Abstract Poster

Authors

Raghav Sundar

Raghav Sundar

Drug Development Unit-The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Raghav Sundar , Guo Wei Kim , Hon Lyn Tan , Lingzhi Wang , Koy Min Chue , Chia Hui Tai , Siok Chin Teo , Clarisse Jang , Corissa Chee , Bettina Lieske , Cheng Ean Chee , Asim Shabbir , Jimmy Bok Yan So , Wei-Peng Yong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03172416

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 360)

Abstract #

360

Poster Bd #

D15

Abstract Disclosures

Similar Posters

First Author: Rosemary Senguttuvan

First Author: Aabha Oza

First Author: Brian D. Badgwell

First Author: Emily Hinchcliff